PIII Share Price Performance
US$9.69
1.88 (24.07%)
5.5% undervalued intrinsic discount
US$10.25
Fair Value
Price US$9.69
AnalystConsensusTarget US$10.25
AnalystLowTarget US$8.00
AnalystHighTarget US$12.50
Fair ValueUS$10.25
Share Pricen/a
P3 Health Partners Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
PIII Community Narratives
AN
Fair Value
·Fair Value US$10.25 5.5% undervalued intrinsic discount
Rising Medicare Eligibility And Value-Based Care Will Expand Markets
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value US$8 21.1% overvalued intrinsic discount
Persistent Regulatory Risk And Consolidation Will Constrain Future Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$12.5 22.5% undervalued intrinsic discount
Aging Demographics And Medicare Advantage Will Redefine Primary Care
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Rising Medicare Eligibility And Value-Based Care Will Expand Markets
Key Takeaways Expansion in the Medicare market and shift to value-based care models position the company for sustained membership, revenue growth, and improved profitability. Technology investments, operational efficiencies, and stronger payer collaborations are creating measurable cost savings, margin expansion, and enhanced revenue opportunities.Read more
AN
US$10.25
5.5% undervalued intrinsic discount
Fair Value
Profit Margin
5.17%
Future PE
0.43x
Price in 2029
US$13.04
Aging Demographics And Medicare Advantage Will Redefine Primary Care
Key Takeaways Operational enhancements, advanced technology, and programmatic cost controls position P3 for meaningful margin and earnings growth beyond market expectations. Strong payer relationships, expanding joint ventures, and industry tailwinds in value-based care support higher, recurring revenue and significant market share gains.Read more
AN
US$12.5
22.5% undervalued intrinsic discount
Fair Value
Profit Margin
5.13%
Future PE
0.49x
Price in 2029
US$15.9
Persistent Regulatory Risk And Consolidation Will Constrain Future Margins
Key Takeaways Regulatory and industry pressures threaten P3's profitability and margins, with potential for unfavorable reimbursement and increased medical costs. Failure to achieve operational improvements or keep pace with digital health trends could lead to sustained losses and market share erosion.Read more
AN
US$8
21.1% overvalued intrinsic discount
Fair Value
Profit Margin
5.39%
Future PE
0.83x
Price in 2028
US$22.5
Trending Discussion
Recently Updated Narratives
AN
PIII: Steady Fair Value View Will Support Constructive Long Term Upside
Fair Value: US$10.25 5.5% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
PIII: Modest Assumption Shifts Will Support Stronger 2026 Upside Potential
Fair Value: US$12.5 22.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Persistent Regulatory Risk And Consolidation Will Constrain Future Margins
Fair Value: US$8 21.1% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
P3 Health Partners Inc. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -38.05
- -0.75%
- -8.58%
- -234.2%
About PIII
- Founded
- 2020
- Employees
- 320
- CEO
- WebsiteView website
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
